logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Chronic Pain

    Medications for Chronic Pain

    FiltersReset Filters
    7 results

    • infumorph 200

      (morphine sulfate)
      Hikma Pharmaceuticals USA Inc.
      Usage: INFUMORPH is indicated for use in continuous microinfusion devices for intrathecal or epidural infusion to manage intractable chronic pain that requires an opioid analgesic when less invasive treatments are ineffective. It is not for single-dose administration to avoid overdose risks. Prolonged use is only recommended if pain remains severe.

    • morphine sulfate

      (Morphine Sulfate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Morphine Sulfate Oral Solution is indicated for managing acute and chronic pain in adults and pediatric patients aged 2 years and older when alternative treatments are inadequate. The 20 mg/mL formulation is specifically for opioid-tolerant adults. Caution is advised due to the risk of addiction and misuse.

    • morphine sulfate

      (Morphine Sulfate)
      SpecGx LLC
      Usage: Morphine Sulfate Tablets are indicated for managing acute and chronic pain in adults when alternative treatments are inadequate. Due to risks of addiction, they should be reserved for patients who cannot tolerate or achieve adequate pain relief from non-opioid analgesics or opioid combinations.

    • morphine sulfate

      (morphine sulfate)
      Upsher-Smith Laboratories, LLC
      Usage: Morphine sulfate tablets are indicated for managing acute pain in adults and pediatric patients (≥ 50 kg) and chronic pain in adults when alternative treatments are inadequate. Use is limited due to risks of addiction, abuse, and misuse, reserved for patients intolerant to or with insufficient relief from other options.

    • morphine sulfate

      (Morphine Sulfate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Morphine Sulfate Tablets are indicated for managing acute pain in patients (adults and children over 50 kg) and chronic pain in adults when alternative treatments are inadequate. Due to addiction risks, the drug should only be used when other analgesics are not tolerated or effective.

    • oxaydo

      (OXYCODONE HYDROCHLORIDE)
      Zyla Life Sciences US LLC
      Usage: OXAYDO is indicated for managing acute and chronic severe pain requiring an opioid analgesic when alternative treatments are inadequate. Due to addiction and misuse risks, it should be reserved for patients who cannot tolerate or achieve adequate relief with non-opioid options. Extended use is discouraged unless necessary.

    • prialt

      (ziconotide acetate)
      TerSera Therapeutics LLC
      Usage: PRIALT (ziconotide) is indicated for managing severe chronic pain in adults requiring intrathecal therapy, particularly for those intolerant to or unresponsive to other treatments, including systemic analgesics and intrathecal morphine.